Advanced Oncotherapy (AVO)
AVO Share PerformanceMore
|52 week high||64.800 02/01/18|
|52 week low||9.525 19/07/17|
|52 week change||11.500 (37.10%)|
|4 week volume||2,401,037 30/03/18|
Media for (AVO)
Presenter: Nicolas Serandour
Presenter: AVO Team
- 1 of 16
Latest News« previous» nextMore
05/04/2018 - 07:00 RNS
RNS Number: 8631J Advanced Oncotherapy PLC 05 April 2018 TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii: Advanced O...
03/04/2018 - 10:05 StockMarketWire
Advanced Oncotherapy said Tuesday that discussions between Yantai Cipu, through its affiliated entity Liquid Harmony, ...
03/04/2018 - 09:43 RNS
RNS Number: 5966J Advanced Oncotherapy PLC 03 April 2018 ADVANCED ONCOTHERAPY PLC ("Advanced Oncotherapy" or the "Company") Update on Distribution Agreement Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that discussions between Yantai Cipu, through its affil...
12/03/2018 - 08:15 RNS
RNS Number: 3227H Advanced Oncotherapy PLC 12 March 2018 Hardman & Co Research: Confidence greatly boosted Confidence greatly boosted: Advanced Oncotherapy (AVO) is focused on delivering a more affordable, novel, proton-based radiotherapy system, based on technology developed originally at the world-renowned CERN. Major technical milestones w...
23/02/2018 - 17:05 RNS
RNS Number: 8369F Advanced Oncotherapy PLC 23 February 2018 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii Advanced Oncotherapy Plc 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting...
16/02/2018 - 08:00 RNS
RNS Number: 0737F Advanced Oncotherapy PLC 16 February 2018 ADVANCED ONCOTHERAPY PLC ("Advanced Oncotherapy" or the "Company") Completion of the Subscription Agreement Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that in relation to the announcement date...
23/01/2018 - 12:48 RNS
RNS Number: 6752C Advanced Oncotherapy PLC 23 January 2018 23 January 2018 ADVANCED ONCOTHERAPY PLC ("Advanced Oncotherapy" or the "Company") Result of GM Advanced Oncotherapy plc (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that at the General Meeting held earlier today, all re...
12/01/2018 - 10:00 StockMarketWire
Dr Enrico Vanni, Non Executive Director, bought 40,000 shares in the company on the 11th January 2018 at a price of 54.5...
|Dividend yield||0 %|
Latest discussion posts More
“Still more upward pressure, news must be imminent! Volumes are tiny though. If bad news was coming then we'd see bigger volumes and more of a drift. ”▼
“Very low turnover”▼
“Anybody heard anything. Maybe the China deal has been signed?”▼
Codes & Symbols
|Symbols||AVO, LSE:AVO, AVO.L, AVO:LN, LON:AVO, XLON:AVO|